Atossa Therapeutics, Inc. (ATOS)
4.80
-0.35
(-6.80%)
USD |
NASDAQ |
Apr 07, 10:05
Atossa Therapeutics SG&A Expense (TTM) : 15.96M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Celldex Therapeutics, Inc. | 43.84M |
| Plus Therapeutics, Inc. | 12.13M |
| Abeona Therapeutics, Inc. | 65.03M |
| Cell Source, Inc. | 1.950M |
| Kiora Pharmaceuticals, Inc. | 5.745M |